Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics and West Virginia University’s ...
At the core of this initiative is Spectris™, Cognito’s investigational, non-invasive neuroprotective device designed for at-home use. Spectris™ has shown early promise in preserving brain structure ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback